<p>A) HeyA8-CXCR4-CBRN/Ar-CBC and parental HeyA8 cells were treated with increasing concentrations of CXCL12 for 10 minutes. Western blot of total cell lysates shows phosphorylated and total AKT, respectively. We used GAPDH as a loading control. Graph shows relative band intensities for phosphorylated AKT in each cell line normalized to total AKT and GAPDH. B) HeyA8-CXCR4-CBRN/Ar-CBC cells were treated with 100 ng/ml CXCL12-α for 0, 5, 15, or 30 minutes in the absence or presence of 1 µM AMD3100. Total cell lysates were probed for phosphorylated and total ERK1/2, respectively. Lysates also were analyzed by Western blot for expression of β-arrestin 2-CBC and endogenous β-arrestin 1 and 2. GAPDH is shown as a loading control. C) Flow cytometr...
International audienceABSTRACT: BACKGROUND: CXCL12 has been widely reported to play a biologically r...
BACKGROUND: The chemokine CXCL12 and its cognate receptor, CXCR4, have been implicated in numerous t...
Epithelial ovarian cancer is characterized by a low recovery rate because the disease is typically d...
Chemokine CXCL12 and receptor CXCR4 have emerged as promising therapeutic targets for ovarian cancer...
<p>Jurkat and HeyA8 cells were cultured under normal growth conditions. For flow cytometry analysis,...
The chemokine CXCL12 and its receptor CXCR4 are expressed widely in human cancers, including ovarian...
Abstract Background CXCL12 has been widely reported to play a biologically relevant role in tumor gr...
Ovarian cancer is the most common type of gynecologic malignancy. Despite advances in surgery and ch...
Abstract Background Previously assumed to be a select ligand for chemokine receptor CXCR4, chemokine...
In the human neoplastic cell lines 5637 and HeLa, recombinant CXCL12 elicited, as expected, downstre...
AbstractPatients with metastatic ovarian cancer continue to have a dismal prognosis, emphasizing the...
Upon binding with the chemokine CXCL12, the chemokine receptor CXCR4 has been shown to promote breas...
This study investigated the prognostic role of the CXCR4-CXCL12-CXCR7 axis in advanced epithelial ov...
CXC ligand (L)12 is a chemokine implicated in the migration, invasion and metastasis of cancer cells...
<p>(A) Qualitative RT-PCR analyses for <i>CXCR7</i> and <i>CXCR4</i> mRNA expression in a panel of N...
International audienceABSTRACT: BACKGROUND: CXCL12 has been widely reported to play a biologically r...
BACKGROUND: The chemokine CXCL12 and its cognate receptor, CXCR4, have been implicated in numerous t...
Epithelial ovarian cancer is characterized by a low recovery rate because the disease is typically d...
Chemokine CXCL12 and receptor CXCR4 have emerged as promising therapeutic targets for ovarian cancer...
<p>Jurkat and HeyA8 cells were cultured under normal growth conditions. For flow cytometry analysis,...
The chemokine CXCL12 and its receptor CXCR4 are expressed widely in human cancers, including ovarian...
Abstract Background CXCL12 has been widely reported to play a biologically relevant role in tumor gr...
Ovarian cancer is the most common type of gynecologic malignancy. Despite advances in surgery and ch...
Abstract Background Previously assumed to be a select ligand for chemokine receptor CXCR4, chemokine...
In the human neoplastic cell lines 5637 and HeLa, recombinant CXCL12 elicited, as expected, downstre...
AbstractPatients with metastatic ovarian cancer continue to have a dismal prognosis, emphasizing the...
Upon binding with the chemokine CXCL12, the chemokine receptor CXCR4 has been shown to promote breas...
This study investigated the prognostic role of the CXCR4-CXCL12-CXCR7 axis in advanced epithelial ov...
CXC ligand (L)12 is a chemokine implicated in the migration, invasion and metastasis of cancer cells...
<p>(A) Qualitative RT-PCR analyses for <i>CXCR7</i> and <i>CXCR4</i> mRNA expression in a panel of N...
International audienceABSTRACT: BACKGROUND: CXCL12 has been widely reported to play a biologically r...
BACKGROUND: The chemokine CXCL12 and its cognate receptor, CXCR4, have been implicated in numerous t...
Epithelial ovarian cancer is characterized by a low recovery rate because the disease is typically d...